Megestrol acetate
مژسترول استات
🎗️ Antineoplastic And Immunomodulating AgentsProgestin
Market / country: 🇺🇸 USA
Megace (US)
🧮 Dose calculator
AIDS-associated anorexia and weight loss · Regimen source: FDA Megestrol susp · Dosage and Administration
- • Daily doses of 400 and 800 mg were effective in trials. Shake well before use. FDA Megestrol susp · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to megestrol acetate; known or suspected pregnancy. FDA Megestrol susp · Contraindications
Warnings
- • Fetal harm; adrenal suppression and Cushingoid effects with chronic use or withdrawal; thromboembolism. FDA Megestrol susp · Warnings
Formulations
- 40 mg/mL oral suspension — suspension 🇺🇸 USA FDA Megestrol susp · How Supplied
👥 Special populations
- 🤰 PregnancyContraindicated
Label: contraindicated in pregnancy. FDA Megestrol susp · CONTRAINDICATIONS
“Known or suspected pregnancy.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Megestrol susp · Nursing Mothers
“Because of the potential for adverse effects on the newborn, nursing should be discontinued if megestrol acetate oral suspension is required.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Megestrol susp · Pediatric Use
“Safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Megestrol susp · Geriatric Use
“In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease of other drug therapy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA075671
- DailyMed (FDA label)FDA Megestrol susp
- MedlinePlus (NIH)Megestrol
- WHO ATC/DDDL02AB01
- Darooyab (Iran)❌ None
🇮🇷 Not found in Iran list Darooyab · search
Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Megestrol susp · How SuppliedFDA Megestrol susp · Dosage and AdministrationFDA Megestrol susp · ContraindicationsFDA Megestrol susp · WarningsFDA Megestrol susp · SPL approval / marketing categoryFDA Megestrol susp · CONTRAINDICATIONSFDA Megestrol susp · Nursing MothersFDA Megestrol susp · Pediatric UseFDA Megestrol susp · Geriatric Use
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · search
- Clinical review⚠ Unverified